Format

Send to

Choose Destination
See comment in PubMed Commons below
PLoS One. 2014 Mar 20;9(3):e92317. doi: 10.1371/journal.pone.0092317. eCollection 2014.

Integrative ChIP-seq/microarray analysis identifies a CTNNB1 target signature enriched in intestinal stem cells and colon cancer.

Author information

  • 1Department of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, California, United States of America.
  • 2Institute for Genomics and Bioinformatics, University of California Irvine, Irvine, California, United States of America; Department of Computer Science, University of California Irvine, Irvine, California, United States of America.
  • 3Rosetta Inpharmatics, LLC, Merck & Co Inc., Seattle, Washington, United States of America.
  • 4Department of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, California, United States of America; Institute for Genomics and Bioinformatics, University of California Irvine, Irvine, California, United States of America.

Abstract

BACKGROUND:

Deregulation of canonical Wnt/CTNNB1 (beta-catenin) pathway is one of the earliest events in the pathogenesis of colon cancer. Mutations in APC or CTNNB1 are highly frequent in colon cancer and cause aberrant stabilization of CTNNB1, which activates the transcription of Wnt target genes by binding to chromatin via the TCF/LEF transcription factors. Here we report an integrative analysis of genome-wide chromatin occupancy of CTNNB1 by chromatin immunoprecipitation coupled with high-throughput sequencing (ChIP-seq) and gene expression profiling by microarray analysis upon RNAi-mediated knockdown of CTNNB1 in colon cancer cells.

RESULTS:

We observed 3629 CTNNB1 binding peaks across the genome and a significant correlation between CTNNB1 binding and knockdown-induced gene expression change. Our integrative analysis led to the discovery of a direct Wnt target signature composed of 162 genes. Gene ontology analysis of this signature revealed a significant enrichment of Wnt pathway genes, suggesting multiple feedback regulations of the pathway. We provide evidence that this gene signature partially overlaps with the Lgr5+ intestinal stem cell signature, and is significantly enriched in normal intestinal stem cells as well as in clinical colorectal cancer samples. Interestingly, while the expression of the CTNNB1 target gene set does not correlate with survival, elevated expression of negative feedback regulators within the signature predicts better prognosis.

CONCLUSION:

Our data provide a genome-wide view of chromatin occupancy and gene regulation of Wnt/CTNNB1 signaling in colon cancer cells.

PMID:
24651522
PMCID:
PMC3961325
DOI:
10.1371/journal.pone.0092317
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Support Center